Frost & Sullivan Honours TransPharma Medical Ltd. for its Innovative ViaDerm Drug Delivery System

Published: Aug 04, 2008

LONDON--(BUSINESS WIRE)--The 2008 Frost & Sullivan European Transdermal Drug Delivery Product Innovation Award is conferred on Israel-based TransPharma Medical Ltd. in recognition of its innovative ViaDerm drug delivery system. The company’s two flagship drug product development programs - ViaDerm hPTH (1-34) for the treatment of osteoporosis and ViaDerm-hGH for the treatment of human growth hormone deficiency – both in phase 2 of clinical development.

Back to news